DarioHealth Corp. (DRIO) Financial Statements (2026 and earlier)

Company Profile

Business Address 322 W 57TH ST. #33B
NEW YORK, NY 10019
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments21,80327,76436,79749,35735,80828,590
Cash and cash equivalent21,80327,76436,79749,35735,80828,590
Short-term investments      
Restricted cash and investments229175292113140135
Receivables(158)(169)  4001,500
Inventory, net of allowances, customer advances and progress billings4,3164,7535,0627,9566,2282,293
Inventory4,3164,7535,0627,9566,2282,293
Prepaid expense 1,5761,7881,5369081,5911,354
Deferred costs258259238483  
Other current assets 5272892502397680
Other undisclosed current assets6,5165,6703,1556,4681,362176
Total current assets:35,06740,52947,33065,52445,60534,128
Noncurrent Assets
Operating lease, right-of-use asset7171,0659671,206287498
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization549709899788702576
Intangible asset, including goodwill, after accumulated amortization73,35876,18947,04451,55654,100 
Goodwill57,42757,42741,64041,64041,640 
Intangible asset, excluding goodwill, after accumulated amortization15,93118,7625,4049,91612,460 
Deposits noncurrent assets8079662020
Deferred costs176655941  
Other undisclosed noncurrent assets128248847057185
Total noncurrent assets:75,00878,35549,05953,66755,1661,279
TOTAL ASSETS:110,075118,88496,389119,191100,77135,407
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,3304,9853,3584,50712,9155,500
Employee-related liabilities✕✕✕✕✕3,4082,140
Accounts payable2,9283,0451,1312,3225,1092,480
Accrued liabilities 2,4021,9402,2272,1854,398880
Deferred revenue7141,5839971,3201,1951,224
Debt  5,4513,9548,823  
Other undisclosed current liabilities3,2794,6164,1844,700266310
Total current liabilities:9,32316,63512,49319,35014,3767,034
Noncurrent Liabilities
Long-term debt and lease obligation30,74723,47224,59118,10521222
Long-term debt, excluding current maturities30,74723,47224,59118,105  
Liabilities, other than long-term debt2,0836,7581,1611,737825 
Other liabilities462536   
Operating lease, liability57176588582721222
Business combination, contingent consideration, liability     825 
Derivative instruments and hedges, liabilities1,4665,968240910  
Total noncurrent liabilities:32,83030,23025,75219,842846444
Total liabilities:42,15346,86538,24539,19215,2227,478
Equity
Equity, attributable to parent67,92272,01958,14479,99985,54928,151
Common stock44332 
Additional paid in capital519,996462,358407,502365,846307,561171,399
Accumulated deficit(452,078)(390,343)(349,361)(285,850)(222,014)(143,248)
Total equity:67,92272,01958,14479,99985,54928,151
Other undisclosed liabilities and equity      (222)
TOTAL LIABILITIES AND EQUITY:110,075118,88496,389119,191100,77135,407

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues22,35927,04020,35227,65620,5137,576
Cost of revenue
(Cost of Product and Service Sold)		(9,694)(13,773)(14,368)(18,001)(12,444)(5,063)
Other undisclosed gross profit     (4,106) 
Gross profit:12,66513,2675,9849,6553,9632,513
Operating expenses(49,320)(71,011)(62,173)(66,465)(80,457)(32,416)
Operating loss:(36,655)(57,744)(56,189)(56,810)(76,494)(29,903)
Nonoperating income (expense)(4,954)13,145(3,174)(5,379)(235)458
Investment income, nonoperating 1,1161,8685064461
Gain (loss), foreign currency transaction, before tax (4)(210)243(195)446
Other nonoperating income (expense)(1,934)     
Interest and debt expense(3,020)  (1,876)  
Loss from continuing operations before equity method investments, income taxes:(44,629)(44,599)(59,363)(64,065)(76,729)(29,445)
Other undisclosed income from continuing operations before income taxes3,020  1,876  
Loss from continuing operations before income taxes:(41,609)(44,599)(59,363)(62,189)(76,729)(29,445)
Income tax expense (benefit)(105)1,852(64)(4)(32) 
Loss from continuing operations:(41,714)(42,747)(59,427)(62,193)(76,761)(29,445)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(76,761)(29,445)
Net loss attributable to parent:(41,714)(42,747)(59,427)(62,193)(76,761)(29,445)
Other undisclosed net income (loss) available to common stockholders, basic    2,236(2,005)(3,658)
Net loss available to common stockholders, diluted:(41,714)(42,747)(59,427)(59,957)(78,766)(33,103)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(41,714)(42,747)(59,427)(62,193)(76,761)(29,445)
Comprehensive loss:(41,714)(42,747)(59,427)(62,193)(76,761)(29,445)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(20,021)1,765(4,084)(1,643)  
Comprehensive loss, net of tax, attributable to parent:(61,735)(40,982)(63,511)(63,836)(76,761)(29,445)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: